首页> 外文期刊>Canadian Journal of Physiology and Pharmacology >Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.
【24h】

Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.

机译:尿激酶型纤溶酶原激活物对动脉重塑和血管生成的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

A wide variety of disorders are associated with an imbalance in the plasminogen activator system, including inflammatory diseases, atherosclerosis, intimal hyperplasia, the response mechanism to vascular injury, and restenosis. Urokinase-type plasminogen activator (uPA) is a multifunctional protein that in addition to its fibrinolytic and matrix degradation capabilities also affects growth factor bioavailability, cytokine modulation, receptor shedding, cell migration and proliferation, phenotypic modulation, protein expression, and cascade activation of proteases, inhibitors, receptors, and modulators. uPA is the crucial protein for neointimal growth and vascular remodeling. Moreover, it was recently shown to be implicated in the stimulation of angiogenesis, which makes it a promising multipurpose therapeutic target. This review is focused on the mechanisms by which uPA can regulate arterial remodeling, angiogenesis, and cell migration and proliferation after arterial injury and the means by which it modulates gene expression in vascular cells. The role of domain specificity of urokinase in these processes is also discussed.
机译:多种疾病与纤溶酶原激活剂系统的失衡有关,包括炎性疾病,动脉粥样硬化,内膜增生,对血管损伤的反应机制和再狭窄。尿激酶型纤溶酶原激活剂(uPA)是一种多功能蛋白,除了其纤溶和基质降解能力外,还影响生长因子的生物利用度,细胞因子调节,受体脱落,细胞迁移和增殖,表型调节,蛋白表达以及蛋白酶的级联激活,抑制剂,受体和调节剂。 uPA是新内膜生长和血管重塑的关键蛋白。此外,最近显示它与刺激血管生成有关,这使其成为有希望的多用途治疗靶标。这篇综述的重点是uPA可以调节动脉损伤后的动脉重构,血管生成以及细胞迁移和增殖的机制,以及其调控血管细胞中基因表达的方式。还讨论了尿激酶结构域特异性在这些过程中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号